Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Clinical Trials Insight: 700030494

Trial Profile

Clinical Trials Insight: 700030494

Phase of Trial: Phase I

Latest Information Update: 16 Jul 2010

At a glance

  • Drugs TM 38837 (Primary)
  • Indications Obesity; Type 2 diabetes mellitus
  • Focus Adverse reactions
  • Sponsors 7TM Pharma
  • Most Recent Events

    • 16 Jul 2010 Results were reported at the 11th International Congress on Obesity.
    • 20 Jan 2010 Status changed from planning to completed.
    • 02 Sep 2008 This trial is expected to be inititated in the first half of 2009.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top